ReviewPatient preference and adherence2024

Novel Bispecific T-Cell Engagers for the Treatment of Relapsed B Cell Non-Hodgkin Lymphomas: Current Knowledge and Treatment Considerations.

Ben Varon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.